Home > Research > Publications & Outputs > Developing a predictive nomogram for colposcopists

Links

Text available via DOI:

View graph of relations

Developing a predictive nomogram for colposcopists: a retrospective, multicenter study of cervical precancer identification in China

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Developing a predictive nomogram for colposcopists: a retrospective, multicenter study of cervical precancer identification in China. / Xue, Peng; Seery, Samuel; Wang, Sumeng et al.
In: BMC Cancer, Vol. 23, No. 1, 163, 17.02.2023.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Xue P, Seery S, Wang S, Jiang Y, Qiao Y. Developing a predictive nomogram for colposcopists: a retrospective, multicenter study of cervical precancer identification in China. BMC Cancer. 2023 Feb 17;23(1):163. doi: 10.1186/s12885-023-10646-3

Author

Xue, Peng ; Seery, Samuel ; Wang, Sumeng et al. / Developing a predictive nomogram for colposcopists : a retrospective, multicenter study of cervical precancer identification in China. In: BMC Cancer. 2023 ; Vol. 23, No. 1.

Bibtex

@article{dcad2e37a9d243249a146c424d19e582,
title = "Developing a predictive nomogram for colposcopists: a retrospective, multicenter study of cervical precancer identification in China",
abstract = "Background: Colposcopic examination with biopsy is the standard procedure for referrals with abnormal cervical cancer screening results; however, the decision to biopsy is controvertible. Having a predictive model may help to improve high-grade squamous intraepithelial lesion or worse (HSIL+) predictions which could reduce unnecessary testing and protecting women from unnecessary harm. Methods: This retrospective multicenter study involved 5,854 patients identified through colposcopy databases. Cases were randomly assigned to a training set for development or to an internal validation set for performance assessment and comparability testing. Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to reduce the number of candidate predictors and select statistically significant factors. Multivariable logistic regression was then used to establish a predictive model which generates risk scores for developing HSIL+. The predictive model is presented as a nomogram and was assessed for discriminability, and with calibration and decision curves. The model was externally validated with 472 consecutive patients and compared to 422 other patients from two additional hospitals. Results: The final predictive model included age, cytology results, human papillomavirus status, transformation zone types, colposcopic impressions, and size of lesion area. The model had good overall discrimination when predicting HSIL + risk, which was internally validated (Area Under the Curve [AUC] of 0.92 (95%CI 0.90–0.94)). External validation found an AUC of 0.91 (95%CI 0.88–0.94) across the consecutive sample, and 0.88 (95%CI 0.84–0.93) across the comparative sample. Calibration suggested good coherence between predicted and observed probabilities. Decision curve analysis also suggested this model would be clinically useful. Conclusion: We developed and validated a nomogram which incorporates multiple clinically relevant variables to better identify HSIL + cases during colposcopic examination. This model may help clinicians determining next steps and in particular, around the need to refer patients for colposcopy-guided biopsies.",
keywords = "Research, Predictive model, Colposcopy, Cervical precancer, Diagnosis",
author = "Peng Xue and Samuel Seery and Sumeng Wang and Yu Jiang and Youlin Qiao",
year = "2023",
month = feb,
day = "17",
doi = "10.1186/s12885-023-10646-3",
language = "English",
volume = "23",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",
number = "1",

}

RIS

TY - JOUR

T1 - Developing a predictive nomogram for colposcopists

T2 - a retrospective, multicenter study of cervical precancer identification in China

AU - Xue, Peng

AU - Seery, Samuel

AU - Wang, Sumeng

AU - Jiang, Yu

AU - Qiao, Youlin

PY - 2023/2/17

Y1 - 2023/2/17

N2 - Background: Colposcopic examination with biopsy is the standard procedure for referrals with abnormal cervical cancer screening results; however, the decision to biopsy is controvertible. Having a predictive model may help to improve high-grade squamous intraepithelial lesion or worse (HSIL+) predictions which could reduce unnecessary testing and protecting women from unnecessary harm. Methods: This retrospective multicenter study involved 5,854 patients identified through colposcopy databases. Cases were randomly assigned to a training set for development or to an internal validation set for performance assessment and comparability testing. Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to reduce the number of candidate predictors and select statistically significant factors. Multivariable logistic regression was then used to establish a predictive model which generates risk scores for developing HSIL+. The predictive model is presented as a nomogram and was assessed for discriminability, and with calibration and decision curves. The model was externally validated with 472 consecutive patients and compared to 422 other patients from two additional hospitals. Results: The final predictive model included age, cytology results, human papillomavirus status, transformation zone types, colposcopic impressions, and size of lesion area. The model had good overall discrimination when predicting HSIL + risk, which was internally validated (Area Under the Curve [AUC] of 0.92 (95%CI 0.90–0.94)). External validation found an AUC of 0.91 (95%CI 0.88–0.94) across the consecutive sample, and 0.88 (95%CI 0.84–0.93) across the comparative sample. Calibration suggested good coherence between predicted and observed probabilities. Decision curve analysis also suggested this model would be clinically useful. Conclusion: We developed and validated a nomogram which incorporates multiple clinically relevant variables to better identify HSIL + cases during colposcopic examination. This model may help clinicians determining next steps and in particular, around the need to refer patients for colposcopy-guided biopsies.

AB - Background: Colposcopic examination with biopsy is the standard procedure for referrals with abnormal cervical cancer screening results; however, the decision to biopsy is controvertible. Having a predictive model may help to improve high-grade squamous intraepithelial lesion or worse (HSIL+) predictions which could reduce unnecessary testing and protecting women from unnecessary harm. Methods: This retrospective multicenter study involved 5,854 patients identified through colposcopy databases. Cases were randomly assigned to a training set for development or to an internal validation set for performance assessment and comparability testing. Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to reduce the number of candidate predictors and select statistically significant factors. Multivariable logistic regression was then used to establish a predictive model which generates risk scores for developing HSIL+. The predictive model is presented as a nomogram and was assessed for discriminability, and with calibration and decision curves. The model was externally validated with 472 consecutive patients and compared to 422 other patients from two additional hospitals. Results: The final predictive model included age, cytology results, human papillomavirus status, transformation zone types, colposcopic impressions, and size of lesion area. The model had good overall discrimination when predicting HSIL + risk, which was internally validated (Area Under the Curve [AUC] of 0.92 (95%CI 0.90–0.94)). External validation found an AUC of 0.91 (95%CI 0.88–0.94) across the consecutive sample, and 0.88 (95%CI 0.84–0.93) across the comparative sample. Calibration suggested good coherence between predicted and observed probabilities. Decision curve analysis also suggested this model would be clinically useful. Conclusion: We developed and validated a nomogram which incorporates multiple clinically relevant variables to better identify HSIL + cases during colposcopic examination. This model may help clinicians determining next steps and in particular, around the need to refer patients for colposcopy-guided biopsies.

KW - Research

KW - Predictive model

KW - Colposcopy

KW - Cervical precancer

KW - Diagnosis

U2 - 10.1186/s12885-023-10646-3

DO - 10.1186/s12885-023-10646-3

M3 - Journal article

VL - 23

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

IS - 1

M1 - 163

ER -